Today's Date
Best Available Therapy Versus Autologous Hematopoetic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
(
BEAT-MS
)
ITN Protocol #:
ITN077AI
Branded Name:
BEAT-MS
ClinicalTrials.Gov ID:
NCT04047628Treatment Protocol #:
Therapeutic Area:
Autoimmune Disease
Current Status:
Enrollment
Summary:
A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis
Clinical Operations Associate Director
Clinical Operations Manager
ITN Biologist
ITN Biostat
ITN Clinical Trial Physician
NIAID Project Manager
NIAID Regulator Officer
Rho Data Manager
Rho Scientist
PPD Lead Monitor
Study Personnel:
